Umedeor: Funding, Investors & Team (Oct 2026)
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams. umed.io
Umedeor has raised $17.3M across 3 funding rounds on record, the most recent a Series A of $12.5M announced in Jul 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Umedeor Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Umedeor Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Umedeor raised $4.8M in an undisclosed round announced in Dec 2020.
2 years later, an undisclosed round was announced in Dec 2022 with no disclosed amount.
7 months later, a Series A of $12.5M was announced in Jul 2023.
Umedeor Founders and Leadership Team
Contact details for the Umedeor team: 1 of 1 has an email address on file.
Start 14-day free trial →Umedeor Funding Compared to Other Biotechnology Startups
Umedeor's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Umedeor in Biotechnology and London
Companies Similar to Umedeor
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Umedeor Funding FAQs
What does Umedeor do?
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams. umed.io
How much funding has Umedeor raised?
Umedeor has raised $17.3M across 3 rounds on record. The most recent is a Series A of $12.5M announced in Jul 2023.
When did Umedeor last raise funding?
Umedeor's most recent funding round on record is a Series A of $12.5M, announced in Jul 2023.
Who is the CEO of Umedeor?
Matt Wilson is listed as CEO at Umedeor.
Where is Umedeor headquartered?
Umedeor is based in London, England, United Kingdom.
How many employees does Umedeor have?
Umedeor is in the 11-50 employee band.
How does Umedeor's funding compare to other Biotechnology startups?
Umedeor's latest round of $12.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Umedeor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Umedeor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.